{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:45:26Z","timestamp":1792215926981,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clbc.2026.08.020","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:01:11Z","timestamp":1788364871000},"page":"169-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes and Chemoprevention in High-Risk Breast Lesions: A Comparison of Atypical Ductal Hyperplasia and Lobular Carcinoma In Situ"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9811-8471","authenticated-orcid":false,"given":"Ye Ryung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5301-7473","authenticated-orcid":false,"given":"Mi Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Hyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Yeup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Uk","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-6855","authenticated-orcid":false,"given":"Woo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clbc.2026.08.020_bib0001","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/bcr623","article-title":"The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)\u2014current definitions and classification","volume":"5","author":"Pinder","year":"2003","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.020_bib0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clbc.2026.08.020_bib0003","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast. A long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.020_bib0004","first-page":"491","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.020_bib0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00000658-199706000-00010","article-title":"Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy","volume":"225","author":"Moore","year":"1997","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.020_bib0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.path.2017.09.009","article-title":"Lobular carcinoma in situ","volume":"11","author":"Wen","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.clbc.2026.08.020_bib0007","series-title":"The 11th Korean Clinical Practice Guideline for Breast Cancer","year":"2025"},{"key":"10.1016\/j.clbc.2026.08.020_bib0008","series-title":"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction. Version 1.2026","year":"2025"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.020_bib0009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.breast.2015.01.006","article-title":"Risk profile of breast cancer following atypical hyperplasia detected through organized screening","volume":"24","author":"Buckley","year":"2015","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.020_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u2014risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2026.08.020_bib0011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1477-7819-7-77","article-title":"Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy","volume":"7","author":"Chae","year":"2009","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.020_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000004849","article-title":"Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision","volume":"276","author":"Kilgore","year":"2022","journal-title":"Ann Surg"},{"issue":"18","key":"10.1016\/j.clbc.2026.08.020_bib0013","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.020_bib0014","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.020_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoncol.2016.3022","article-title":"Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy","volume":"3","author":"Menes","year":"2017","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.020_bib0016","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1245\/s10434-024-14947-0","article-title":"Upgrade rates and breast cancer development among germline pathogenic variant carriers with high-risk breast lesions","volume":"31","author":"Laws","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2026.08.020_bib0017","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1245\/s10434-024-15788-7","article-title":"Trajectory of subsequent breast cancer diagnoses in a diverse patient cohort with breast atypia","volume":"31","author":"Limberg","year":"2024","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:32:25Z","timestamp":1792215145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1526820926001588"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.020","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes and Chemoprevention in High-Risk Breast Lesions: A Comparison of Atypical Ductal Hyperplasia and Lobular Carcinoma In Situ","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}